The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer
Crossref DOI link: https://doi.org/10.1245/s10434-017-5903-6
Published Online: 2017-05-30
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakhlis, Faina
Regan, Meredith M.
Warren, Laura E.
Bellon, Jennifer R.
Hirshfield-Bartek, Judith
Duggan, Margaret M.
Dominici, Laura S.
Golshan, Mehra
Jacene, Heather A.
Yeh, Eren D.
Mullaney, Erin E.
Overmoyer, Beth
License valid from 2017-05-30